John Fahey, the president of the World Anti-Doping Agency, said in an interview with the Australian Broadcasting Corp. that Roche planted a molecule in its red-cell boosting product CERA, or Continuous Erythropoietin Receptor Activator, during its manufacture to help anti-doping authorities detect its illegal use. Roche sells the drug as Mircera.